Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Titel:
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Auteur:
Albrecht, Lea Jessica Dimitriou, Florentia Grover, Piyush Hassel, Jessica C. Erdmann, Michael Forschner, Andrea Johnson, Douglas B. Váraljai, Renáta Lodde, Georg Placke, Jan Malte Krefting, Frederik Zaremba, Anne Ugurel, Selma Roesch, Alexander Schulz, Carsten Berking, Carola Pöttgen, Christoph Menzies, Alexander M. Long, Georgina V. Dummer, Reinhard Livingstone, Elisabeth Schadendorf, Dirk Zimmer, Lisa